Literature DB >> 31993867

Efficacy of Dupilumab for Controlling Severe Atopic Dermatitis in a Patient with Hyper-IgE Syndrome.

Romain Lévy1,2,3, Vivien Béziat4,5, Claire Barbieux5,6, Anne Puel4,5, Emmanuelle Bourrat7, Jean-Laurent Casanova4,5,8,9,10, Alain Hovnanian11,12.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31993867     DOI： 10.1007/s10875-020-00751-4

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  5 in total

1.  Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.

Authors:  Eric L Simpson; Thomas Bieber; Emma Guttman-Yassky; Lisa A Beck; Andrew Blauvelt; Michael J Cork; Jonathan I Silverberg; Mette Deleuran; Yoko Kataoka; Jean-Philippe Lacour; Külli Kingo; Margitta Worm; Yves Poulin; Andreas Wollenberg; Yuhwen Soo; Neil M H Graham; Gianluca Pirozzi; Bolanle Akinlade; Heribert Staudinger; Vera Mastey; Laurent Eckert; Abhijit Gadkari; Neil Stahl; George D Yancopoulos; Marius Ardeleanu
Journal:  N Engl J Med       Date:  2016-09-30       Impact factor: 91.245

2.  Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.

Authors:  Lisa A Beck; Diamant Thaçi; Jennifer D Hamilton; Neil M Graham; Thomas Bieber; Ross Rocklin; Jeffrey E Ming; Haobo Ren; Richard Kao; Eric Simpson; Marius Ardeleanu; Steven P Weinstein; Gianluca Pirozzi; Emma Guttman-Yassky; Mayte Suárez-Fariñas; Melissa D Hager; Neil Stahl; George D Yancopoulos; Allen R Radin
Journal:  N Engl J Med       Date:  2014-07-10       Impact factor: 91.245

3.  ZNF341 controls STAT3 expression and thereby immunocompetence.

Authors:  Stefanie Frey-Jakobs; Julia M Hartberger; Manfred Fliegauf; Claudia Bossen; Magdalena L Wehmeyer; Johanna C Neubauer; Alla Bulashevska; Michele Proietti; Philipp Fröbel; Christina Nöltner; Linlin Yang; Jessica Rojas-Restrepo; Niko Langer; Sandra Winzer; Karin R Engelhardt; Cristina Glocker; Dietmar Pfeifer; Adi Klein; Alejandro A Schäffer; Irina Lagovsky; Idit Lachover-Roth; Vivien Béziat; Anne Puel; Jean-Laurent Casanova; Bernhard Fleckenstein; Stephan Weidinger; Sara S Kilic; Ben-Zion Garty; Amos Etzioni; Bodo Grimbacher
Journal:  Sci Immunol       Date:  2018-06-15

4.  A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity.

Authors:  Vivien Béziat; Juan Li; Jian-Xin Lin; Cindy S Ma; Peng Li; Aziz Bousfiha; Isabelle Pellier; Samaneh Zoghi; Safa Baris; Sevgi Keles; Paul Gray; Ning Du; Yi Wang; Yoann Zerbib; Romain Lévy; Thibaut Leclercq; Frédégonde About; Ai Ing Lim; Geetha Rao; Kathryn Payne; Simon J Pelham; Danielle T Avery; Elissa K Deenick; Bethany Pillay; Janet Chou; Romain Guery; Aziz Belkadi; Antoine Guérin; Mélanie Migaud; Vimel Rattina; Fatima Ailal; Ibtihal Benhsaien; Matthieu Bouaziz; Tanwir Habib; Damien Chaussabel; Nico Marr; Jamel El-Benna; Bodo Grimbacher; Orli Wargon; Jacinta Bustamante; Bertrand Boisson; Ingrid Müller-Fleckenstein; Bernhard Fleckenstein; Marie-Olivia Chandesris; Matthias Titeux; Sylvie Fraitag; Marie-Alexandra Alyanakian; Marianne Leruez-Ville; Capucine Picard; Isabelle Meyts; James P Di Santo; Alain Hovnanian; Ayper Somer; Ahmet Ozen; Nima Rezaei; Talal A Chatila; Laurent Abel; Warren J Leonard; Stuart G Tangye; Anne Puel; Jean-Laurent Casanova
Journal:  Sci Immunol       Date:  2018-06-15

Review 5.  Primary atopic disorders.

Authors:  Jonathan J Lyons; Joshua D Milner
Journal:  J Exp Med       Date:  2018-03-16       Impact factor: 14.307
  5 in total
  1 in total

Review 1.  Biologic Therapies for the Management of Cutaneous Findings in Genodermatoses: A Review.

Authors:  Tejas P Joshi; Hannah Y Wang; Prazwal Athukuri; Sarah Bohac; Morgan A Farr; Darien Hinson; Justin A Kahla; Nasim Khalfe; Dylan B McBee; Rachel Stroh; Nicole Walters; Vicky Ren
Journal:  Am J Clin Dermatol       Date:  2022-05-23       Impact factor: 6.233
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.